Mitogen-activated protein kinase activity may not be necessary for the neuropathology of Niemann-Pick type C mice

Journal of Neurochemistry

Volumn 107, Issue 3, 2008, Pages 814-822

  Zhang, Min ^a,b   Hallows, Janice L ^b   Wang, Xuezhen ^a   Bu, Bitao ^a   Wang, Wei ^a   Vincent, Inez ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Axonal spheroids; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Oligodendrocytes; Tau phosphorylation; Tauopathy

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NEUROPATHOLOGY; NIEMANN PICK DISEASE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FLAVONOIDS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INJECTIONS, INTRAVENTRICULAR; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROFILAMENT PROTEINS; NIEMANN-PICK DISEASE, TYPE C; OLIGODENDROGLIA; PHOSPHORYLATION; TAU PROTEINS;

MUS;

EID: 53749100314     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05657.x     Document Type: Article

References (46)

1. Arima K., Nakamura M., Sunohara N., Ogawa M., Anno M., Izumiyama Y., Hirai S. Ikeda K. (1997) Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol. (Berl) 93, 558 566.
2. Bakare O., Ashendel C. L., Peng H., Zalkow L. H. Burgess E. M. (2003) Synthesis and MEK1 inhibitory activities of imido-substituted 2-chloro-1,4-naphthoquinones. Bioorg. Med. Chem. 11, 3165 3170.
3. Bi X., Liu J., Yao Y., Baudry M. Lynch G. (2005) Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain. Am. J. Pathol. 167, 1081 1092.
4. Bjorkblom B., Ostman N., Hongisto V., Komarovski V., Filen J. J., Nyman T. A., Kallunki T., Courtney M. J. Coffey E. T. (2005) Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J. Neurosci. 25, 6350 6361.
5. Bu B., Li J., Davies P. Vincent I. (2002a) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22, 6515 6525.
6. Bu B., Klunemann H., Suzuki K., Li J., Bird T., Jin L. W. Vincent I. (2002b) Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol. Dis. 11, 285 297.
7. Choe E. S. McGinty J. F. (2001) Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum in vivo. J. Neurochem. 76, 401 412.
8. Dangi S. Shapiro P. (2005) Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosis. J. Biol. Chem. 280, 24524 24531.
9. De Azevedo W. F., Leclerc S., Meijer L., Havlicek L., Strnad M. Kim S. H. (1997) Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 243, 518 526.
10. Elleder M. Jirasek A. (1981) Neuropathology of various types of Niemann-Pick disease. Acta Neuropathol. Suppl. 7, 201 203.
11. Elleder M., Jirasek A., Smid F., Ledvinova J. Besley G. T. (1985) Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol. 66, 325 336.
12. Ferrer I., Blanco R., Carmona M. Puig B. (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural. Transm. 108, 1397 1415.
13. Ferrer I., Pastor P., Rey M. J., Munoz E., Puig B., Pastor E., Oliva R. Tolosa E. (2003a) Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol. Appl. Neurobiol. 29, 23 34.
14. Ferrer I., Barrachina M., Tolnay M., Rey M. J., Vidal N., Carmona M., Blanco R. Puig B. (2003b) Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Brain Pathol. 13, 62 78.
15. German D. C., Quintero E. M., Liang C., Xie C. Dietschy J. M. (2001) Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 105, 999 1005.
16. Goedert M., Spillantini M. G. Davies S. W. (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8, 619 632.
17. Goold R. G. Gordon-Weeks P. R. (2005) The MAP kinase pathway is upstream of the activation of GSK3beta that enables it to phosphorylate MAP1B and contributes to the stimulation of axon growth. Mol. Cell. Neurosci. 28, 524 534.
18. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M. Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913 4917.
19. Hallows J. L., Chen K., DePinho R. A. Vincent I. (2003) Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J. Neurosci. 23, 10633 10644.
20. Higashi Y., Murayama S., Pentchev P. G. Suzuki K. (1993) Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. 85, 175 184.
21. Higuchi M., Zhang B., Forman M. S., Yoshiyama Y., Trojanowski J. Q. Lee V. M. (2005) Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. J. Neurosci. 25, 9434 9443.
22. Jin C., Katayama S., Hiji M., Watanabe C., Noda K., Nakamura S. Matsumoto M. (2006) Relationship between neuronal loss and tangle formation in neurons and oligodendroglia in progressive supranuclear palsy. Neuropathology 26, 50 56.
23. Josephs K. A., Mandrekar J. N. Dickson D. W. (2006) The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat. Disord. 12, 109 112.
24. Lew J. Wang J. H. (1995) Neuronal cdc2-like kinase. Trends Biochem. Sci. 20, 33 37.
25. Loftus S. K., Morris J. A., Carstea E. D. et al. (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277, 232 235.
26. Loftus S. K., Erickson R. P., Walkley S. U., Bryant M. A., Incao A., Heidenreich R. A. Pavan W. J. (2002) Rescue of neurodegeneration in Niemann-Pick C mice by a prion-promoter-driven Npc1 cDNA transgene. Hum. Mol. Genet. 11, 3107 3114.
27. Mori T., Wang X., Jung J. C., Sumii T., Singhal A. B., Fini M. E., Dixon C. E., Alessandrini A. Lo E. H. (2002) Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444 452.
28. Namgung U. Xia Z. (2000) Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J. Neurosci. 20, 6442 6451.
29. Pant H. C. Veeranna (1995) Neurofilament phosphorylation. Biochem. Cell Biol. 73, 575 592.
30. Paudel H. K., Lew J., Ali Z. Wang J. H. (1993) Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 268, 23512 23518.
31. Qui M. S. Green S. H. (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9, 705 717.
32. Richter-Landsberg C. Bauer N. G. (2004) Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition. Int. J. Dev. Neurosci. 22, 443 451.
33. Sawamura N., Gong J. S., Garver W. S., Heidenreich R. A., Ninomiya H., Ohno K., Yanagisawa K. Michikawa M. (2001) Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J. Biol. Chem. 4, 4.
34. Sawamura N., Gong J. S., Chang T. Y., Yanagisawa K. Michikawa M. (2003) Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells. J. Neurochem. 84, 1086 1096.
35. Sharma P., Veeranna, Sharma M., Amin N. D., Sihag R. K., Grant P., Ahn N., Kulkarni A. B. Pant H. C. (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528 534.
36. Suzuki K., Parker C. C., Pentchev P. G., Katz D., Ghetti B., D'Agostino A. N. Carstea E. D. (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 89, 227 238.
37. Takahashi M., Weidenheim K. M., Dickson D. W. Ksiezak-Reding H. (2002) Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 61, 33 45.
38. Takikita S., Fukuda T., Mohri I., Yagi T. Suzuki K. (2004) Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J. Neuropathol. Exp. Neurol. 63, 660 673.
39. Vincent I., Jicha G., Rosado M. Dickson D. W. (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588 3598.
40. Vincent I., Zheng J. H., Dickson D. W., Kress Y. Davies P. (1998) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19, 287 296.
41. Vincent I., Bu B. Erickson R. P. (2003a) Understanding Niemann-Pick type C disease: a fat problem. Curr. Opin. Neurol. 16, 155 161.
42. Vincent I., Pae C. I. Hallows J. L. (2003b) The cell cycle and human neurodegenerative disease. Prog. Cell Cycle Res. 5, 31 34.
43. Voikar V., Rauvala H. Ikonen E. (2002) Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease. Behav. Brain Res. 132, 1 10.
44. Waetzig V. Herdegen T. (2005) MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling. Mol. Cell. Neurosci. 30, 67 78.
45. Zhang M., Li J., Chakrabarty P., Bu B. Vincent I. (2004) Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am. J. Pathol. 165, 843 853.
46. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H. Smith M. A. (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435 441.